Following fast tracked COVID-19 mRNA vaccine approvals, the industry has been held back by a lack of regulatory clarity for mRNA process development and manufacturing. Despite this, innovations in flexible platform technologies, computational modelling and continuous flow manufacturing are optimising processes to accelerate mRNA manufacturing to aid mRNA applications for personalised medicines and beyond. 

The 2nd mRNA Process Development & Manufacturing Summit Europe was put together with industry experts to improve and optimise your mRNA sequence design, purification processes, platforms for circular and self-amplifying RNAs, drug product formulation and scale up processes. Our 2024 audience joined 100+ large pharma, innovative biotech and pioneering academics at Europe’s only industry-led forum to enhance robust process optimisation and scale up for regulatory standards to accelerate routes to market.